10 Important Things to Know About Tecentriq Immunotherapy for Lung Cancer

1. Tecentriq (atezolizumab) is a type of immunotherapy drug used to treat certain types of lung cancer. It works by boosting the body's immune system to help fight cancer cells.

2. Tecentriq is approved by the U.S. Food and Drug Administration (FDA) for the treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body.

3. Immunotherapy with Tecentriq is typically used when other treatments, such as chemotherapy, have not been effective or have stopped working.

4. Tecentriq is given as an intravenous infusion, usually every 3 weeks. The treatment schedule may vary depending on the individual patient's condition and response to the drug.

5. Common side effects of Tecentriq may include fatigue, loss of appetite, nausea, diarrhea, and skin rash. More serious side effects, such as immune-related reactions, may also occur and should be reported to a healthcare provider immediately.

6. Before starting treatment with Tecentriq, patients should discuss their medical history, current medications, and any other health conditions with their healthcare team. This will help ensure the safest and most effective treatment plan.

7. It is important for patients receiving Tecentriq immunotherapy to attend all scheduled appointments and follow-up visits with their healthcare provider. This will allow for close monitoring of their condition and response to treatment.

8. In some cases, Tecentriq may be used in combination with other cancer treatments, such as chemotherapy or targeted therapy. This approach, known as combination therapy, may help improve outcomes for some patients with lung cancer.

9. Patients undergoing treatment with Tecentriq should be aware of the potential risks and benefits of immunotherapy and discuss any concerns or questions with their healthcare team. Open communication is key to ensuring the best possible care and treatment outcomes.

10. As with any cancer treatment, it is important for patients to stay informed, ask questions, and advocate for themselves throughout the treatment process. By working closely with their healthcare team, patients can help ensure the best possible outcomes and quality of life while undergoing immunotherapy for lung cancer.